Results 12,001-12,020 of 32,978 for speaker:Catherine Connolly
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: How many go to taxation?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: One figure struck me when I was reading through the documentation. Only 3% of cases end up in court ultimately. It seems 97% are settled outside of court, yet the costs are extraordinarily high.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Whichever way it arises, only 3% actually end up in court.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: I will come back to the matter of thalidomide when the Chairman indicates I have five minutes left. I have a question for Mr. McCallion on the audit. I have followed up on this because it is so important. The view was that we were misinterpreting what the audit was about and that its purpose was to enable the system to learn. It was not really for the women, although women would...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Why has it not been reintroduced? Has the service not learned and does it know what to do now?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: I hear that and I hear that more experts are being appointed. However, as a woman and a politician, what jumped out at me was the patronising and terrible attitude to women. They should have been at the core. It is not so difficult to change. If the audit is an essential tool, as we know it is, it is simply taking too long and immediate steps have to be taken. It is now months and months...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: It has taken more than the cost of the running of the service to learn some basic lessons. Anyone who reads the briefing documents can see it is obvious that the woman was not at the core of this. It was a matter of protection. I will not waste any more time on it.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: I have read all of that. I am commenting on the passage of time to achieve what should have been fundamental to the process.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: When will the audit be reinstated?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: I wish to discuss two final matters on the clinical side. I will then come to the question of thalidomide. I have been trying to get my head around things. I have a personal involvement so I apologise if my question was not clear enough at a previous meeting. Mr. Breen was not here but the question arose in a different context. We want to get value for money. We also want an...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: I understand that and that much is clear. Should that information be available? Does anyone from the Department of Health wish to comment?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Yes, it is done from outside of the hospital. I was specific in my question. It struck me as an extraordinary lack of disclosure. We are talking about disclosure and cost. I will return to that point but as I have only a couple of minutes left, I will discuss thalidomide. My question is for Mr. Breen. There are two accounts. In respect of the 2016 accounts, Mr. Breen referred to 34...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: One second, please. Will Mr. Breen explain the difference between the 2016 and 2017 figures, given that there were an extra nine in 2016 and just 34 in 2017?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: Do we know how many victims of thalidomide there were in Ireland?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: From the Government or the German authorities?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: There are two ex gratiapayments.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: There are 30 people who are receiving ex gratiapayments from the Government.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: From the State and the German company.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: That is 23 out of the 30.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Catherine Connolly: In addition, they receive other medical benefits.